Quick Answer
REGENEREX PHARMA, INC. reported Long Term Debt of $184.2 thousand for the year ending 2024.
- This data is from REGENEREX PHARMA, INC.'s annual report (Form 10-K), filed with the SEC on June 30, 2025.
- XBRL data for this metric is available from 2024 to 2024 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: